Subscribe To Our Free Newsletter |
Sun Pharma slips 3% after OAI status from USFDA for Dadra facility
In an exchange filing Sun Pharma said, the US Food and Drug Administration (US FDA) conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023